Shopping Cart 0
Cart Subtotal
USD 0

AVEO Pharmaceuticals Inc (AVEO) - Financial and Strategic SWOT Analysis Review

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 125

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 250

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 375
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

AVEO Pharmaceuticals Inc (AVEO) Financial and Strategic SWOT Analysis Review provides you an in depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

Business description A detailed description of the company's operations and business divisions.

Corporate strategy Analyst's summarization of the company's business strategy.

SWOT Analysis A detailed analysis of the company's strengths, weakness, opportunities and threats.

Company history Progression of key events associated with the company.

Major products and services A list of major products, services and brands of the company.

Key competitors A list of key competitors to the company.

Key employees A list of the key executives of the company.

Executive biographies A brief summary of the executives' employment history.

Key operational heads A list of personnel heading key departments/functions.

Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.

Key manufacturing facilities A list of key manufacturing facilities of the company.

Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi annual financial statements published by the company for 5 interims history.

Highlights

AVEO Pharmaceuticals Inc (AVEO) is a biopharmaceutical company which focuses on the discovery, development and commercialization of drugs for the treatment of various types of cancers. Its proprietary platform delivers insights into cancer and related diseases. AVEO develops its lead candidate tivozanib in North America as a treatment for renal cell carcinoma and other cancers. The company has strategic partnerships with EUSA, Novartis, Pharmstandard Group, Ophthotech Corporation, Biodesix Kyowa Hakko Kirin; Astellas Pharma, Biogen Idec International GmbH and others. AVEO is headquartered in Cambridge, Massachusetts, the US.

AVEO Pharmaceuticals Inc Key Recent Developments

Mar 13,2018: AVEO Reports Full Year 2017 Financial Results and Provides Business Update

Nov 20,2017: AVEO Announces Appointment of Nikhil Mehta, Ph.D., as Senior Vice President of Regulatory and Quality Assurance

Nov 07,2017: AVEO Reports Third Quarter 2017 Financial Results and Provides Business Update

Aug 09,2017: AVEO Reports Second Quarter 2017 Financial Results and Provides Business Update

May 16,2017: AVEO Oncology appoints new CFO

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Section 1 About the Company 5

AVEO Pharmaceuticals Inc Key Facts 5

AVEO Pharmaceuticals Inc Key Employees 6

AVEO Pharmaceuticals Inc Key Employee Biographies 7

AVEO Pharmaceuticals Inc Major Products and Services 8

AVEO Pharmaceuticals Inc History 9

AVEO Pharmaceuticals Inc Company Statement 11

AVEO Pharmaceuticals Inc Locations And Subsidiaries 12

Head Office 12

Other Locations & Subsidiaries 12

Section 2 Company Analysis 13

Company Overview 13

AVEO Pharmaceuticals Inc Business Description 14

AVEO Pharmaceuticals Inc Corporate Strategy 15

AVEO Pharmaceuticals Inc SWOT Analysis 16

SWOT Analysis Overview 16

AVEO Pharmaceuticals Inc Strengths 16

AVEO Pharmaceuticals Inc Weaknesses 17

AVEO Pharmaceuticals Inc Opportunities 18

AVEO Pharmaceuticals Inc Threats 19

AVEO Pharmaceuticals Inc Key Competitors 20

Section 3 Company Financial Ratios 21

Financial Ratios Capital Market Ratios 21

Financial Ratios Annual Ratios 22

Performance Chart 24

Financial Performance 24

Financial Ratios Interim Ratios 25

Financial Ratios Ratio Charts 26

Section 4 Company's Lifesciences Financial Deals and Alliances 27

AVEO Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 27

AVEO Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 28

AVEO Pharmaceuticals Inc, Recent Deals Summary 29

Section 5 Company's Recent Developments 30

Mar 13, 2018: AVEO Reports Full Year 2017 Financial Results and Provides Business Update 30

Nov 20, 2017: AVEO Announces Appointment of Nikhil Mehta, Ph.D., as Senior Vice President of Regulatory and Quality Assurance 33

Nov 07, 2017: AVEO Reports Third Quarter 2017 Financial Results and Provides Business Update 34

Aug 09, 2017: AVEO Reports Second Quarter 2017 Financial Results and Provides Business Update 36

May 16, 2017: AVEO Oncology appoints new CFO 38

May 04, 2017: AVEO Reports First Quarter 2017 Financial Results and Provides Business Update 39

Mar 22, 2017: AVEO Reports Full Year 2016 Financial Results and Provides Business Update 41

Section 6 Appendix 43

Methodology 43

Ratio Definitions 43

About GlobalData 47

Contact Us 47

Disclaimer 47


List Of Figure

List of Figures

AVEO Pharmaceuticals Inc, Performance Chart (2013 2017) 24

AVEO Pharmaceuticals Inc, Ratio Charts 26

AVEO Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 27

AVEO Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 28


List Of Table

List of Tables

AVEO Pharmaceuticals Inc, Key Facts 5

AVEO Pharmaceuticals Inc, Key Employees 6

AVEO Pharmaceuticals Inc, Key Employee Biographies 7

AVEO Pharmaceuticals Inc, Major Products and Services 8

AVEO Pharmaceuticals Inc, History 9

AVEO Pharmaceuticals Inc, Subsidiaries 12

AVEO Pharmaceuticals Inc, Key Competitors 20

AVEO Pharmaceuticals Inc, Ratios based on current share price 21

AVEO Pharmaceuticals Inc, Annual Ratios 22

AVEO Pharmaceuticals Inc, Annual Ratios (Cont...1) 23

AVEO Pharmaceuticals Inc, Interim Ratios 25

AVEO Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 27

AVEO Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 28

AVEO Pharmaceuticals Inc, Recent Deals Summary 29

Currency Codes 43

Capital Market Ratios 43

Equity Ratios 44

Profitability Ratios 44

Cost Ratios 45

Liquidity Ratios 45

Leverage Ratios 46

Efficiency Ratios 46

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

AVEO Pharmaceuticals Inc, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Companies

Roche Laboratories Inc

Onyx Pharmaceuticals Inc

Novartis Pharmaceuticals Corp

Mirati Therapeutics Inc

Merrimack Pharmaceuticals Inc

Galaxy Biotech LLC

Daiichi Sankyo Inc